2026-05-01
0 officials
Politician(s) lobbied: Unknown
Intent: Unknown
Methods: Unknown
Details by Method
Method not specified
Unknown
All Officials
Select methods...
Lobbying Records (Page 1 of 1)
2026-01-16
1 official
Politician(s) lobbied: Seán Kelly (MEP), European Parliament
Intent: Highlight the contributions that Clonmel Healthcare has made to the local community and our commitment to supplying affordable medicines in Ireland.
Methods: Event / Reception
Details by Method
Event / Reception
Celebrating Clonmel Healthcare's 55 Years in business. The event was attended by employees and took place at the Clonmel Healthcare premises in Clonmel.
2025-09-18
0 officials
Politician(s) lobbied: Unknown
Intent: Unknown
Methods: Unknown
Details by Method
Method not specified
Unknown
2025-05-13
1 official
Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health
Intent: To arrange a meeting on behalf of Medicines For Ireland (MFI) with the Minister of Health, Jennifer Carol MacNeill to discuss and defer the implementation of the UWWTD in it's current format. MFI believe that this Directive will have a severe negative impact on patient access to critical and essential generic medicines.
Methods: Event / Reception
Details by Method
Event / Reception
Briefly met the Minister of Health Jennifer Carrol MacNeill at the Celebration of Women in Leadership event on March 27th 2025. Jacky Byrne (Private Secretary) was also in attendance. The encounter was followed up with a letter to Jacky Byrne requesting a formal meeting for Medicines for Ireland (MFI) to engage directly with the Minister to outline the far-reaching implications of the UWWTD from a patient and manufacturing implication perspective.
2024-12-05
2 officials
Politician(s) lobbied: Barry Andrews (MEP), European Parliament; Darragh O'Brien (Minister), Department of Housing, Local Government and Heritage
Intent: Request that our representatives in Europe, encourage the European Council to delay the vote on the recast UWWTD until a full impact assessment can be done, one that accurately estimates the true costs to patients and Europe’s/Ireland’s generic medicine supply. If the vote proceeds, then to request that the implementation of the directive locally in Ireland is reassessed.
Methods: Meeting
Details by Method
Meeting
- Meeting with MEP Barry Andrews - Location, European Parliament Office Dublin- Attended by representatives from Clonmel Healthcare, Medicines for Ireland (MFI) and Irish Pharmaceutical Healthcare Association (IPHA). - Requesting the deferral on the impending vote to enact the UWWTD
2024-12-05
2 officials
Politician(s) lobbied: Darragh O'Brien (TD), Dáil Éireann, the Oireachtas; Stephen Donnelly (TD), Dáil Éireann, the Oireachtas
Intent: To ensure that Irish patients benefit from cost-effective and innovative healthcare solutions. Biosimilar medicines, such as Ustekinumab, offer substantial contributions to healthcare savings. To expedite the use of such biosimilars which are subject to the Framework Agreement on the Supply and Pricing of Medicines 2021. Highlighting Clonmel's Ustekinumab biosimilar with potential savings of at least 55%. Expedite these savings by endorsing biosimilars ahead of the BVB process.::Request that our representatives in Europe, encourage the European Council to delay the vote on the recast UWWTD until a full impact assessment can be done, one that accurately estimates the true costs to patients and Europe’s/Ireland’s generic medicine supply. If the vote proceeds, then to request that the implementation of the directive locally in Ireland is reassessed.
Methods: Meeting
Details by Method
Meeting
- Meeting with Stephen Donnelly, Minister of Health.- Location, Ministers office at Government Buildings.- To expedite the usage of biosimilars such as Ustekinumab in order to deliver significant savings to the overall health budget.